The methamphetamine problem in the United States

Annual Review of Public Health

Volumn 31, Issue , 2010, Pages 385-398

  Gonzales, Rachel ^a   Mooney, Larissa ^a   Rawson, Richard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Interventions; Key trends; Risk populations; Social consequences

Indexed keywords

METHAMPHETAMINE;

DRUG USE; EPIDEMIOLOGICAL DATA; HEALTH BEHAVIOR; HISTORY; HUMAN; MALE HOMOSEXUAL; OFFENDER; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SOCIAL BEHAVIOR; UNITED STATES;

ADOLESCENT; CHILD; CRIME; DATA COLLECTION; FEMALE; HOMOSEXUALITY, MALE; HUMANS; MALE; METHAMPHETAMINE; SOCIAL ENVIRONMENT; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VULNERABLE POPULATIONS;

EID: 77951995255     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.012809.103600     Document Type: Review

References (111)

1. Anglin MD, BurkeC, PerrochetB, StamperE, Dawud-NoursiS. 2000. Historyofthe methamphetamine problem. J. Psychoactive Drugs 32(2):137-142
2. Battaglia J, Moss S, Rush J, Kang J, Mendoza R. 1997. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am. J. Emerg. Med. 15:335-340
3. Bostwick MJ, Lineberry TW. 2006. The 'meth' epidemic: managing acute psychosis, agitation, and suicide risk. Curr. Psychiatry Online 5(11):46-60
4. Brecht ML, Greenwell L, Anglin MD. 2005. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002). J. Subst. Abuse Treat. 29(4):295-306
5. Brecht ML, Huang D, Evans E, Hser YI. 2008. Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug Alcohol Depend. 96(3):193-201
6. Brecht ML, O'Brien A, von Mayrhauser C, Anglin MD. 2004. Methamphetamine use behaviors and gender differences. Addict. Behav. 29(1):89-106
7. Brown AH, Domier CP, Rawson RA. 2005. Stimulants, sex & gender: sexual addiction and compulsivity. J. Treat. Prev. 12(2-3):169-180
8. Buchacz K, McFarland W, Kellogg TA, Loeb L, Holmberg SD, et al. 2005. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 19(13):1423-1424 (Pubitemid 41800679)
9. Cent. Dis. Control Prev. 2005. HIV/AIDS Surveillance Report, 2004, Vol. 16. Atlanta, GA: US Dep. Health Hum. Serv.
10. Cent. Dis. Control Prev. 2007. HIV/AIDS among men who have sex with men. http://www. cdc. gov/hiv/topics/msm/resources/factsheets/msm. htm
11. Cheng-Fang Y, Hsiao-Yen W, Ju-Yu Y, Chih-Hung K. 2004. Effects of brief cognitive-behavioral interventions on confidence to resist the urges to use heroin and methamphetamine in relapse-related situations. J. Nerv. Ment. Dis. 192(11):788-791
12. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA. 2003. Treatment of methamphetamine abuse: research findings and clinical directions. J. Subst. Abuse Treat. 24(3):267-277
13. Curtis EK. 2006. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen. Dent. 54(2):125-129
14. Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, et al. 2008. The epidemiology of metham-phetamine use and harm in Australia. Drug Alcohol Rev. 27(3):243-252
15. Dobkin C, Nicosia N. 2009. The war on drugs: methamphetamine, public health and crime. Am. Econ. Rev. 99(1):324-349
16. Dunn MG, Tarter RE, Mezzich AC, Vanyukov M, Kirisci L, KirillovaG. 2002. Origins and consequences of child neglect in substance abuse families. Clin. Psychol. Rev. 22(7):1063-1090
17. Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, et al. 2008. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 33(5):1162-1170
18. Evans E, Longshore D. 2004. Evaluation of the substance abuse and crime prevention act: treatment clients and program types during the first year of implementation. J. Psychoactive Drugs Suppl. 2:165-174
19. Farabee D, Prendergast M, Cartier L. 2002. Methamphetamine use and HIV risk among substance-abusing offenders in California. J. Psychoactive Drugs 34:295-300
20. Freese TE, Miotto K, Reback CJ. 2002. The effects and consequences of selected club drugs. J. Subst. Abuse Treat. 23(2):151-156
21. Frosch D, Shoptaw S, Huber A, Rawson RA, Ling W. 1996. Sexual HIV risk among gay and bisexual male methamphetamine abusers. J. Subst. Abuse Treat. 13(6):483-486
22. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA. 2008. Identifying methamphetamine users at risk for major depressive disorder: findings from the Methamphetamine Treatment Project at 3-year follow-up. Am. J. Addict. 17:99-102
23. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA. 2009. Psy-chopathology in methamphetamine dependent adults 3 years after treatment. Drug Alcohol Rev. In press
24. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA, Metham-phetamine Treatment Project Corporate Authors. 2008. Risk factors for suicide attempts in metham-phetamine dependent patients. Am. J. Addict. 17(1):24-27
25. Gonzales R, Ang A, Marinelli-Casey P, Glik D, Iguchi YM, Rawson R. 2009. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1 year period. J. Subst. Abuse Treat. In press
26. Gonzales R, Ang A, McCann M, Rawson R. 2008. Methamphetamine use among treatment seeking youth: an emerging problem? Subst. Abus. 29(2):71-80
27. Gonzales R, Rawson R. 2005. Methamphetamine addiction: Does treatment work? Couns. Mag. Addict. Prof. 6:16-23
28. Griffiths P, Mravcik V, Lopez D, Klempova D. 2008. Quite a lot of smoke but very limited fire\the use of methamphetamine in Europe. Drug Alcohol Rev. 27(3):236-242
29. Halkitis PN, Shrem MT, Martin FW. 2005. Sexual behavior patterns of methamphetamine-using gay and bisexual men. Subst. Use Misuse 40(5):703-719
30. Haning W, Goebert D. 2007. Electrocardiographic abnormalities in methamphetamine abusers. Addiction 102(Suppl. 1):70-75
31. Harris D, Batki SL. 2000. Stimulant psychosis: symptom profile and acute clinical course. Am. J. Addict. 9(1):28-37
32. Hendrickson R, Cloutier R, McConnell K. 2008. Methamphetamine-related emergency department utilization and cost. Acad. Emerg. Med. 15(1):23-31
33. Hildyard KL, Wolfe DA. 2002. Child neglect: developmental issues and outcomes. Child Abuse Negl. 26(6-7):679-695
34. Hiller ML, Webster JM, Garrity TF, Leukefeld C, Narevic E, Staton M. 2005. Prisoners with substance abuse and mental health problems: use of health and health services. Am. J. Alcohol Abuse 31(1):1-20
35. Hillhouse M, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA, Methamphetamine Treatment Project Corporate Authors. 2007. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction 102(Suppl. 1):84-95
36. Holton WC. 2001. Unlawful lab leftovers. Environ. Health Perspect. 109(12):A576
37. Hser YI, Evans E, Huang D, Brecht ML, Li L. 2008. Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addict. Behav. 33(12):1581-1589
38. Hser Y-I, EvansE, Yu-ChuangH. 2005. Treatmentoutcomesamong womenand men methamphetamine abusers in California. J. Subst. Abuse Treat. 28:77-85
39. Huddleston CW, U. S. Dep. Justice, Off. Justice Progr. 2005. Drug courts: an effective strategy for communities facing methamphetamine. Bur. Justice Assist. Bull. May:1-15. http://www. ojp. usdoj. gov/BJA/pdf/MethDrugCourts. pdf
40. Iguchi MY, London JA, Forge NG, Hickman L, Fain T, Riehman K. 2002. Elements of well-being affected by criminalizing the drug user. Public Health Rep. 117(Suppl. 1):S146-50
41. Ireland TO. 2002. Child maltreatment. In Encyclopedia of Crime and Punishment, Vol. 1, ed. D Levinson, pp. 185-192 Great Barrington, MA: Berkshire Ref. Works
42. Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, et al. 1994. Patients with methamphetamine psychosis admittedtoapsychiatric hospitalinJapan. Apreliminary report. Acta. Psychiatr. Scand. 89(6):428-432
43. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. 2009. Monitoring the future national results on adolescent drug use: overview of key findings, 2008. NIH Publ. No. 09-7401. Bethesda, MD: Natl. Inst. Drug Abuse
44. Karch SB. 2002. Synthetic stimulants. In Karch's Pathology of Drug Abuse, ed. SB Karch, pp. 233-280 Boca Raton, FL: CRC. 3rd ed.
45. Kaye S, McKetin R, Duflou J, Darke S. 2007. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 102:1204-1211
46. Kay-Lambkin FJ. 2008. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence. Drug Alcohol Rev. 27(3):318-325
47. King GR, Ellinwood EH. 2005. Amphetamines and other stimulants. In Substance Abuse: A Comprehensive Textbook, ed. JH Lowinson, P Ruiz, RB Millman, JG Langrod, pp. 277-302. Philadelphia, PA: Lippincott Williams & Wilkins. 4th ed.
48. Klasser GD, Epstein J. 2005. Methamphetamine and its impact on dental care. J. Can. Dent. Assoc. 71(10):759-762
49. Kyle AD, Hansell B. 2005. The Meth Epidemic in America: Two Surveys of U. S. Counties. Washington, DC: Natl. Assoc. Cties. (NACO)
50. Longshore D, Hawken A, Urada D, Anglin MD. 2006. SACPA Cost Analysis Report (First and Second Years). Prepared for the Dep. Alcohol Drug Progr., Calif. Health Hum. Serv. Agency. Los Angeles: UCLA Integr. Subst. Abuse Progr.
51. Low KG, Gendaszek AE. 2002. Illicit use of psychostimulants among college students: a preliminary study. Psychol. Health Med. 7(3):283-287
52. Lundh H, Tunving K. 1981. An extrapyramidal choreiform syndrome caused by amphetamine addiction. J. Neurol. Neurosurg. Psychiatry 44:728-730
53. MacKenzie RG, Heischober B. 1997. Methamphetamine. Pediatr. Rev. 18(9):305-309
54. Marinelli-Casey P, Gonzales R, Hillhouse M, Ang A, Zweben J, et al., Methamphetamine Treatment Project Corporate Authors. 2008. Drug court treatment for methamphetamine dependence: treatment response and post-treatment outcomes. J. Subst. Abuse Treat. 34(2):242-248
55. Mattson R, Calvery JR. 1968. Dextro-amphetamine-sulfate-induced dyskinesias. JAMA 204:108-110
56. Maxwell JC, Rutkowski BA. 2008. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. Drug Alcohol Rev. 27(3):229-235
57. McCabe SE, Knight JR, Teter CJ, Wechsler H. 2005. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100(1):96-106
58. McKetin R, Kozel N, Douglas J, Ali R, Vicknasingam B, et al. 2008. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev. 27(3):220-228
59. McKetin R, McLaren J, Lubman DI, Hides L. 2006. The prevalence of psychotic symptoms among methamphetamine users. Addiction 101(10):1473-1478
60. Messina N, Grella C, Burdon W, Prendergast M. 2007. Childhood adverse events and current traumatic distress: a comparison of men and women prisoners. Crim. Justice Behav. 34(11):1385-1401
61. Messina N, Marinelli-Casey P, Hillhouse M, Rawson R, Hunter J, Ang A. 2008. Childhood adverse events and methamphetamine use among men and women. J. Psychoactive Drugs Suppl. 5:399-409
62. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. 2005. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 79(2):273-277
63. Montoya ID, Vocci F. 2008. Novel medications to treat addictive disorders. Curr. Psychiatry Rep. 10(5):392-398
64. Mooney LJ, Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, et al. 2009. Medical illness in methamphetamine dependent patients 3 years post-treatment. J. Addict. Med. In press
65. Mooney LJ, Glasner-Edwards S, Rawson RA, Ling W. 2009. Medical effects of methamphetamine use. In Methamphetamine Addiction: From Basic Science to Treatment, ed. JM Roll, RA Rawson, W Ling, S Shoptaw, pp. 117-142 New York: Guilford
66. Natl. Drug Intell. Cent. 2007. National Methamphetamine Threat Assessment 2008. Washington, DC: US Dep. Justice. http://www. usdoj. gov/ndic/pubs26/ 26594/index. htm
67. Natl. Inst. Drug Abuse. 2006. Community Epidemiology Work Group (CEWG). Epidemiologic Trends in Drug Abuse. Rockville, MD: US Dep. Health Hum. Serv.
68. Natl. Survey Child Adolesc. Well-Being (NSCAW) Res. Group. 2002. Methodological lessons from the National Survey of Child and Adolescent Well-Being: the first three years of the USA's first national probability study of children and families investigated for abuse and neglect. Child. Youth Serv. Rev. 24(6, 7):513-541
69. Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, et al. 2004. Association between quantitative EEG and neurocognition in methamphetamine- dependent volunteers. Clin. Neurophysiol. 115:194-198
70. Newton TF, Roache JD, De La Garza R 2nd, Fong T, Wallace CL, et al. 2006. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31(7):1537-1544
71. Nicosia N, Pacula RL, Kilmer B, Lundberg R, Chiesa J. 2009. The Economic Cost of Metham-phetamine Use in the United States, 2005. Santa Monica, CA: Drug Policy Res. Cent., RAND Corp.
72. http://www. rand. org/pubs/monographs/MG829/
73. Patterson TL, Semple SJ, Zians JK, Strathdee SA. 2005. Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use. J. Urban Health 82(1, Suppl. 1):i120-26
74. Perez JA Jr, Arsura EL, Strategos S. 1999. Methamphetamine-related stroke: four cases. J. Emerg. Med. 17(3):469-471
75. Petit MR, Curtis PA. 1997. Child Abuse and Neglect: A Look at the States. Washington, DC: Child Welfare League Am.
76. RawsonRA, CondonTP. 2007. Whydoweneed anAddictionsupplement focusedonmethamphetamine? Addiction 102(Suppl. 1):1-4
77. Rawson RA, Gonzales RG, Brethen P. 2002. Treatment of methamphetamine use disorders: an update. J. Subst. Abuse Treat. 23:145-150
78. Rawson RA, Gonzales RG, Ling W. 2006. Methamphetamine abuse and dependence: an update. Dir. Psychiatr. 26(3):221-236
79. Rawson RA, Gonzales R, McCann MJ, Obert J. 2005. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J. Subst. Abuse Treat. 29:67-74
80. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, et al., Methamphetamine Treatment Project Corporate Authors. 2004. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99:708-717
81. Rawson RA, Washton A, Domier CP, Reiber C. 2002. Drugs and sexual effects: role of drug type and gender. J. Subst. Abuse Treat. 22:103-108
82. Rhee KJ, Albertson TE, Douglas JC. 1988. Choreoathetoid disorder associated with amphetamine-like drugs. Am. J. Emerg. Med. 6:131-133
83. Richards JR, Bretz SW, Johnson EB, TurnipseedSD, BrofeldtBT, DerletRW. 1999. Methamphetamine abuse and emergency department utilization. West. J. Med. 170(4):198-202
84. RippethJD, HeatonRK, CareyCL, MarcotteTD, MooreDJ, et al. 2004. Methamphetaminedependence increases riskofneuropsychological impairmentinHIV infected persons. J. Int. Neuropsychol. Soc. 10(1):1-14
85. Roll JM, Huber A, Sodano R, Chudzynski J, Moynier E, Shoptaw S. 2006. A comparison of five reinforcement schedules for use in contingency management-based treatment of methamphetamine abuse. Psycholog. Rec. 56(1):67-81
86. Santos AP, Wilson AK, Hornung CA, Polk HC, Rodriguez JL, Franklin GA. 2005. Methamphetamine laboratory explosions: a new and emerging burn injury. J. Burn Care Rehabil. 26(3):228-232
87. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, et al. 2007. Neurocognitive effects of metham-phetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17(3):275-297
88. Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Kao UH, Wang PC, et al. 2008. Bupropion hydrochlo-ride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. J. Addict. Dis. 27(1):13-23
89. Shoptaw S, Peck J, Reback CJ, Rotheram-Fuller E. 2003. Psychiatric and substance dependence comor-bidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J. Psychoactive Drugs 35(Suppl. 1):161-168
90. Shoptaw S, Reback CJ. 2007. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction 102(Suppl. 1):130-135
91. Shoptaw S, Reback CJ, Freese TE. 2002. Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J. Addict. Dis. 21(1):91-115
92. ShoptawS, Reback CJ, Peck JA, YangX, Rotheram-FullerE, et al. 2005. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 78(2):125-134
93. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. 2000. Cognitive impairment in individuals currently using methamphetamine. Am. J. Addict. 9(3):222-231
94. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, et al. 2006. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118(3):1149-1156
95. Sperling LS, Horowitz JL. 1994. Methamphetamine-induced choreoathetosis and rhabdomyolysis. Ann. Int. Med. 121:986
96. Subst. Abuse Ment. Health Serv. Adm., Cent. Subst. Abuse Treatment. 2001. Multiple Indicator Analysis: Using Secondary Data to Analyze Illicit Drug Use. Publication No. (SMA) 01-3539. Rockville, MD: U. S. Department of Health and Human Services. http://csat. samhsa. gov/MIA/main. html
97. Subst. Abuse Ment. Health Serv. Adm., Off. Appl. Stud. 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Ser. H-34, DHHS Publ. No. SMA08-4343. Rockville, MD: US Dep. Health Hum. Serv.
98. Subst. Abuse Ment. Health Serv. Adm., Off. Appl. Stud. 2009. Treatment Episode Data Set (TEDS). Highlights\2007. National Admissions to Substance Abuse Treatment Services. DASIS Ser. S-45, DHHS Publ. No. (SMA 09-4360. Rockville, MD: US Dep. Health Hum. Serv.
99. Tiihonen J, Kuoppasalmi K, Föhr J, Tuomola P, Kuikanmäki O, et al. 2007. A comparisonof aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am. J. Psychiatry 164:160-162
100. Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA. 2003. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J. Emerg. Med. 24:369-373
101. Ujike H, Sato M. 2004. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N. Y. Acad. Sci. 1025:279-287
102. Urada D, Longshore D. 2007. SACPA offenders. In Evaluation of the Substance Abuse and Crime Prevention Act Final Report, pp. 12-32. Los Angeles: UCLA Integr. Subst. Abuse Progr. http://www. uclaisap. org/prop36/documents/ SACPAEvaluationReport. pdf
103. U. S. Drug Enforc. Adm. 2000. Statistics. Washington, DC: U. S. Drug Enforc. Adm. www. usdoj. gov/dea
104. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, et al. 2001. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21(23):9414-9418
105. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, et al. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158(3):377-382
106. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, et al. 2004. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am. J. Psychiatry 161(2):242-248
107. Westover AN, McBride S, Haley RW. 2007. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch. Gen. Psychiatry 64(4):495-502
108. Westover AN, Nakonezny PA, Haley RW. 2008. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend. 96(1-2):49-56
109. Winslow BT, Voorhees KI, Pehl KA. 2007. Methamphetamine abuse. Am. Fam. Physician 76(8):1169-1174
110. Wong W, Chaw JK, Kent CK, Klausner JD. 2005. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex. Transm. Dis. 32:458-463
111. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, et al. 2004. Psychiatric symptoms in methamphetamine users. Am. J. Addict. 13(2):181-190